AEDIFICA (AED.BR) Fundamental Analysis & Valuation

EBR:AED • BE0003851681

Current stock price

72.65 EUR
-1.55 (-2.09%)
Last:

This AED.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. AED.BR Profitability Analysis

1.1 Basic Checks

  • In the past year AED was profitable.
  • In the past year AED had a positive cash flow from operations.
  • Each year in the past 5 years AED has been profitable.
  • Each year in the past 5 years AED had a positive operating cash flow.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • The Return On Assets of AED (2.73%) is comparable to the rest of the industry.
  • AED has a Return On Equity of 4.96%. This is comparable to the rest of the industry: AED outperforms 48.84% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.52%, AED is in line with its industry, outperforming 55.81% of the companies in the same industry.
  • AED had an Average Return On Invested Capital over the past 3 years of 3.33%. This is in line with the industry average of 3.74%.
  • The 3 year average ROIC (3.33%) for AED is below the current ROIC(3.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
  • AED's Profit Margin has declined in the last couple of years.
  • AED has a Operating Margin of 77.70%. This is in the better half of the industry: AED outperforms 74.42% of its industry peers.
  • AED's Operating Margin has been stable in the last couple of years.
  • AED has a Gross Margin of 97.93%. This is amongst the best in the industry. AED outperforms 97.67% of its industry peers.
  • AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. AED.BR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AED is destroying value.
  • Compared to 1 year ago, AED has about the same amount of shares outstanding.
  • The number of shares outstanding for AED has been increased compared to 5 years ago.
  • Compared to 1 year ago, AED has a worse debt to assets ratio.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • AED has an Altman-Z score of 0.89. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AED (0.89) is comparable to the rest of the industry.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 24.91, AED is in line with its industry, outperforming 41.86% of the companies in the same industry.
  • AED has a Debt/Equity ratio of 0.58. This is a neutral value indicating AED is somewhat dependend on debt financing.
  • AED's Debt to Equity ratio of 0.58 is fine compared to the rest of the industry. AED outperforms 67.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.89
ROIC/WACC0.56
WACC6.25%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
  • With a Current ratio value of 0.35, AED perfoms like the industry average, outperforming 44.19% of the companies in the same industry.
  • A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
  • AED's Quick ratio of 0.35 is in line compared to the rest of the industry. AED outperforms 48.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. AED.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.94% over the past year.
  • Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
  • Looking at the last year, AED shows a quite strong growth in Revenue. The Revenue has grown by 8.06% in the last year.
  • The Revenue has been growing by 23.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.25% on average over the next years.
  • Based on estimates for the next years, AED will show a quite strong growth in Revenue. The Revenue will grow by 8.28% on average per year.
EPS Next Y4.51%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
EPS Next 5Y3.25%
Revenue Next Year6.81%
Revenue Next 2Y8.41%
Revenue Next 3Y7.55%
Revenue Next 5Y8.28%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

3

4. AED.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.17 indicates a correct valuation of AED.
  • Compared to the rest of the industry, the Price/Earnings ratio of AED is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of AED to the average of the S&P500 Index (25.79), we can say AED is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 13.74, the valuation of AED can be described as correct.
  • Based on the Price/Forward Earnings ratio, AED is valued a bit more expensive than the industry average as 65.12% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 23.80. AED is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.17
Fwd PE 13.74
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AED is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, AED is valued a bit more expensive than the industry average as 69.77% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 33.33
EV/EBITDA 21.81
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)3.36
PEG (5Y)N/A
EPS Next 2Y3.64%
EPS Next 3Y3.55%

3

5. AED.BR Dividend Analysis

5.1 Amount

  • AED has a Yearly Dividend Yield of 3.91%. Purely for dividend investing, there may be better candidates out there.
  • AED's Dividend Yield is slightly below the industry average, which is at 5.46.
  • AED's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.91%

5.2 History

  • The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
  • AED's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AED.BR Fundamentals: All Metrics, Ratios and Statistics

AEDIFICA

EBR:AED (3/19/2026, 1:17:15 PM)

72.65

-1.55 (-2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-13
Earnings (Next)04-27
Inst Owners40.43%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.45B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts82.22
Price Target81.75 (12.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.91%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.72%
PT rev (3m)8.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.33%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 15.17
Fwd PE 13.74
P/S 9.79
P/FCF 33.33
P/OCF 11.83
P/B 0.97
P/tB 1
EV/EBITDA 21.81
EPS(TTM)4.79
EY6.59%
EPS(NY)5.29
Fwd EY7.28%
FCF(TTM)2.18
FCFY3%
OCF(TTM)6.14
OCFY8.45%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.36
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.89
F-Score7
WACC6.25%
ROIC/WACC0.56
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.51%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
EPS Next 5Y3.25%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.81%
Revenue Next 2Y8.41%
Revenue Next 3Y7.55%
Revenue Next 5Y8.28%
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.93%
EBIT Next 3Y6.64%
EBIT Next 5Y11.79%
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR Fundamental Analysis FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 3 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 15.17 and the Price/Book (PB) ratio is 0.97.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.